Alzheimer's Type
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo (NCT02192554) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2014-06-01 |
| Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type (NCT01922258) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2013-09-01 |
| A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation (NCT01862640) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2013-07-11 |
Track Alzheimer's Type automatically
Every clearance here is in the API, with alerts when new ones post.